Target intelligence / Profile preview

microRNA 378a (miR-378a)

Target
miR-378a
Molecular classification
microRNA, Small non-coding RNA, Post-transcriptional gene regulator, Other
01

Overview

microRNA 378a (miR-378a) is a highly conserved small non-coding RNA belonging to the microRNA family and is encoded in the first intron of the PPARGC1B gene. It is processed into two mature strands, miR-378a-3p and miR-378a-5p, both of which participate in the post-transcriptional regulation of gene expression. miR-378a plays key roles in regulating energy metabolism, mitochondrial function, autophagy, and differentiation, and displays critical effects on cancer biology by influencing proliferation, migration, invasion, apoptosis, and angiogenesis. It has been implicated in a variety of diseases, including several cancers (where it acts as both an oncogene and tumor suppressor depending on the tissue and context), type 2 diabetes, obesity, cardiovascular disease, and liver fibrosis. miR-378a is currently studied as a potential therapeutic target and biomarker, with experimental strategies including synthetic inhibitors, mimics, and RNA-loaded nanoparticles being evaluated for disease treatment or management[1][3][5].

Other names
hsa-miR-378aMIR378MIR378AMIRN378miRNA378microRNA 378hsa-mir-378hsa-mir-378amiR-378miR-378a-3pmiR-378a-5p
02

Mechanism of action

miR-378a inhibitors: block miR-378a function, altering expression of downstream targets to influence apoptosis, proliferation, and metabolism[1] miR-378a mimics: restore or enhance miR-378a activity to regulate gene expression involved in metabolic homeostasis, tumor growth, or fibrosis[1] Molecular sponges (circRNAs/lncRNAs): sequester miR-378a to modulate its biological effects[3]

03

Biological functions

Regulation of energy and glucose homeostasisRegulation of mitochondrial metabolismRegulation of autophagyCell proliferationApoptosisCell differentiationAngiogenesisCancer cell invasion and migrationRegulation of cell cycleOther
04

Disease associations

Cancer (multiple types, with dual roles as both oncogene and tumor suppressor depending on context)Metabolic diseases (e.g., type 2 diabetes, obesity, hepatosteatosis)Cardiovascular diseaseLiver fibrosisOther
05

Safety considerations

Potential for pleiotropic (multiple, sometimes opposing) effects, as miR-378a can act as both an oncogene and tumor suppressor in different contexts[3][4]Challenges in targeted and tissue-specific delivery of miRNA mimics or inhibitorsOff-target gene regulation and unintended effects on cellular functions[1]Immune response or toxicity from delivery vehicles (e.g., nanoparticles)[1]
06

Interacting drugs

No approved drugs directly targeting miR-378a as of 2024

2 more in the full profile.

07

Biomarkers

miR-378a (or miR-378a-3p/5p) expression as diagnostic/prognostic biomarker in cancers (e.g., gastric cancer, cervical cancer), hepatosteatosis, and metabolic diseases[1][3]Expression levels in serum, tissue, or extracellular vesicles correlate with disease state or prognosis[3]

Beyond the preview

Go deeper on microRNA 378a (miR-378a).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 378a (miR-378a).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call